{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:40:46Z","timestamp":1791297646148,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Astrogliosis as seen in Multiple Sclerosis (MS) develops into astroglial scarring, which is beneficial because it seals off the site of central nervous system (CNS) damage. However, astroglial scarring also forms an obstacle that inhibits axon outgrowth and (re)myelination in brain lesions. This is possibly an important cause for incomplete remyelination in the CNS of early stage MS patients and for failure in remyelination when the disease progresses. In this study we address whether under demyelinating conditions <jats:italic>in vivo<\/jats:italic>, tissue Transglutaminase (TG2), a Ca<jats:sup>2+<\/jats:sup> -dependent enzyme that catalyses posttranslational modification of proteins, contributes to extracellular matrix (ECM) deposition and\/or aggregation. We used the cuprizone model for de- and remyelination. TG2 immunoreactivity and enzymatic activity time-dependently appeared in astrocytes and ECM, respectively, in the corpus callosum of cuprizone-treated mice. Enhanced presence of soluble monomeric and multimeric fibronectin was detected during demyelination, and fibronectin immunoreactivity was slightly decreased in cuprizone-treated TG2<jats:sup>\u2212\/\u2212<\/jats:sup> mice. <jats:italic>In vitro<\/jats:italic> TG2 overexpression in astrocytes coincided with more, while knock-down of TG2 with less fibronectin production. TG2 contributes, at least partly, to fibronectin production, and may play a role in fibronectin deposition during cuprizone-induced demyelination. Our observations are of interest in understanding the functional implications of TG2 during astrogliosis.<\/jats:p>","DOI":"10.1038\/srep40995","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T10:38:37Z","timestamp":1485513517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination"],"prefix":"10.1038","volume":"7","author":[{"given":"Nathaly","family":"Espitia Pinzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Sanz-Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J. P.","family":"Brev\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G. J. M.","family":"Bol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Drukarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wia","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"BFsrep40995_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen, N. & S\u00f8rensen, P. S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9, 520\u201332 (2010).","journal-title":"Lancet Neurol."},{"key":"BFsrep40995_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrneurol.2010.1","volume":"6","author":"AE Handel","year":"2010","unstructured":"Handel, A. E., Giovannoni, G., Ebers, G. C. & Ramagopalan, S. V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat. Rev. Neurol. 6, 156\u201366 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"BFsrep40995_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u201317 (2008).","journal-title":"Lancet"},{"key":"BFsrep40995_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold, A. et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet. Neurol. 9, 921\u201332 (2010).","journal-title":"Lancet. Neurol."},{"key":"BFsrep40995_CR5","doi-asserted-by":"publisher","first-page":"II30","DOI":"10.1007\/s00415-007-2009-2","volume":"254","author":"C Engel","year":"2007","unstructured":"Engel, C., Greim, B. & Zettl, U. K. Diagnostics of cognitive dysfunctions in multiple sclerosis. J. Neurol. 254 Suppl, II30\u20134 (2007).","journal-title":"J. Neurol."},{"key":"BFsrep40995_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00415-008-6001-2","volume":"255","author":"T Korn","year":"2008","unstructured":"Korn, T. Pathophysiology of multiple sclerosis. J. Neurol. 255 Suppl, 2\u20136 (2008).","journal-title":"J. Neurol."},{"key":"BFsrep40995_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann, H., Br\u00fcck, W. & Lucchinetti, C. F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17, 210\u20138 (2007).","journal-title":"Brain Pathol."},{"key":"BFsrep40995_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4","volume":"46","author":"JH Van Waesberghe","year":"1999","unstructured":"Van Waesberghe, J. H. et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46, 747\u2013754 (1999).","journal-title":"Ann. Neurol."},{"key":"BFsrep40995_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278\u201385 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep40995_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B","volume":"48","author":"C Bjartmar","year":"2000","unstructured":"Bjartmar, C., Kidd, G., Mork, S., Rudick, R. & Trapp, B. D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48, 893\u2013901 (2000).","journal-title":"Ann. Neurol."},{"key":"BFsrep40995_CR11","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1016\/j.febslet.2011.08.004","volume":"585","author":"H Lassmann","year":"2011","unstructured":"Lassmann, H. & van Horssen, J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett. 585, 3715\u201323 (2011).","journal-title":"FEBS Lett"},{"key":"BFsrep40995_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","volume":"45","author":"GG Ortiz","year":"2014","unstructured":"Ortiz, G. G. et al. Role of the Blood-Brain Barrier in Multiple Sclerosis. Arch. Med. Res. 45, 687\u2013697 (2014).","journal-title":"Arch. Med. Res."},{"key":"BFsrep40995_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","volume":"98","author":"BD Trapp","year":"1999","unstructured":"Trapp, B. D., B\u00f6, L., M\u00f6rk, S. & Chang, A. Pathogenesis of tissue injury in MS lesions. J. Neuroimmunol. 98, 49\u201356 (1999).","journal-title":"J. Neuroimmunol."},{"key":"BFsrep40995_CR14","first-page":"232","volume":"41","author":"D Zhang","year":"2010","unstructured":"Zhang, D., Hu, X. & Qian, L. Astrogliosis in CNS Pathologies: Is There A Role for Microglia? 41, 232\u2013241 (2010).","journal-title":"Astrogliosis in CNS Pathologies: Is There A Role for Microglia?"},{"key":"BFsrep40995_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1750-3639.2007.00110.x","volume":"18","author":"E Gray","year":"2008","unstructured":"Gray, E., Thomas, T. L., Betmouni, S., Scolding, N. & Love, S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 18, 86\u201395 (2008).","journal-title":"Brain Pathol."},{"key":"BFsrep40995_CR16","doi-asserted-by":"crossref","unstructured":"Hostenbach, S., Cambron, M., D\u2019haeseleer, M., Kooijman, R. & De Keyser, J. Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci. Lett. 10\u201312 (2014).","DOI":"10.1016\/j.neulet.2013.10.012"},{"key":"BFsrep40995_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fphar.2012.00120","volume":"3","author":"S Wiese","year":"2012","unstructured":"Wiese, S., Karus, M. & Faissner, A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front. Pharmacol. 3, 120 (2012).","journal-title":"Front. Pharmacol"},{"key":"BFsrep40995_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/glia.10259","volume":"43","author":"S Meeuwsen","year":"2003","unstructured":"Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R. & van Noort, J. M. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243\u201353 (2003).","journal-title":"Glia"},{"key":"BFsrep40995_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/glia.20236","volume":"52","author":"GM Smith","year":"2005","unstructured":"Smith, G. M. & Strunz, C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52, 209\u201318 (2005).","journal-title":"Glia"},{"key":"BFsrep40995_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. & Brown, M. A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164\u20131171 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFsrep40995_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew, M. V. & Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol. 119, 7\u201335 (2010).","journal-title":"Acta Neuropathol."},{"key":"BFsrep40995_CR22","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/glia.20546","volume":"55","author":"A Williams","year":"2007","unstructured":"Williams, A., Piaton, G. & Lubetzki, C. Astrocytes - Friends or Foes in Multiple Sclerosis? Glia 55, 1300\u20131312 (2007).","journal-title":"Glia"},{"key":"BFsrep40995_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0361-9230(99)00072-6","volume":"49","author":"JW Fawcett","year":"1999","unstructured":"Fawcett, J. W. & Asher, R. A. The glial scar and central nervous system repair. Brain Res. Bull. 49, 377\u201391 (1999).","journal-title":"Brain Res. Bull."},{"key":"BFsrep40995_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrn1326","volume":"5","author":"J Silver","year":"2004","unstructured":"Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146\u201356 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFsrep40995_CR25","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/brain\/awr014","volume":"134","author":"MR Kotter","year":"2011","unstructured":"Kotter, M. R., Stadelmann, C. & Hartung, H.-P. Enhancing remyelination in disease\u2013can we wrap it up? Brain 134, 1882\u2013900 (2011).","journal-title":"Brain"},{"key":"BFsrep40995_CR26","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.febslet.2011.03.048","volume":"585","author":"KA Hanafy","year":"2011","unstructured":"Hanafy, K. A. & Sloane, J. A. Regulation of remyelination in multiple sclerosis. FEBS Lett. 585, 3821\u20138 (2011).","journal-title":"FEBS Lett"},{"key":"BFsrep40995_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrm1014","volume":"4","author":"L Lorand","year":"2003","unstructured":"Lorand, L. & Graham, R. M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4, 140\u201356 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFsrep40995_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","volume":"27","author":"L Fesus","year":"2002","unstructured":"Fesus, L. & Piacentini, M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27, 534\u2013539 (2002).","journal-title":"Trends Biochem. Sci."},{"key":"BFsrep40995_CR29","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1111\/j.1742-4658.2011.08346.x","volume":"278","author":"AM Belkin","year":"2011","unstructured":"Belkin, A. M. Extracellular TG2: emerging functions and regulation. FEBS J. 278, 4704\u201316 (2011).","journal-title":"FEBS J."},{"key":"BFsrep40995_CR30","doi-asserted-by":"publisher","first-page":"40212","DOI":"10.1074\/jbc.M110.123703","volume":"285","author":"Z Wang","year":"2010","unstructured":"Wang, Z. et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4\/2 \u03b15\u03b21 integrin co-signaling. J. Biol. Chem. 285, 40212\u201329 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep40995_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1083\/jcb.148.4.825","volume":"148","author":"SS Akimov","year":"2000","unstructured":"Akimov, S. S., Krylov, D., Fleischman, L. F. & Belkin, A. M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148, 825\u201338 (2000).","journal-title":"J. Cell Biol."},{"key":"BFsrep40995_CR32","doi-asserted-by":"crossref","unstructured":"Van Strien, M. E. et al. Astrocyte-derived tissue Transglutaminase interacts with fibronectin: A role in astrocyte adhesion and migration? PLoS One 6 (2011).","DOI":"10.1371\/journal.pone.0025037"},{"key":"BFsrep40995_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1750-3639.2010.00428.x","volume":"21","author":"ME Van Strien","year":"2011","unstructured":"Van Strien, M. E. et al. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration? Brain Pathol. 21, 44\u201354 (2011).","journal-title":"Brain Pathol"},{"key":"BFsrep40995_CR34","first-page":"653","volume":"60","author":"M Griffin","year":"1979","unstructured":"Griffin, M., Smith, L. L. & Wynne, J. Changes in Transglutaminase Activity in an Experimental Model of Pulmonary Fibrosis. Br. J. Exp. Pathol. 60, 653\u2013661 (1979).","journal-title":"Br. J. Exp. Pathol."},{"key":"BFsrep40995_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0168-8278(01)00135-0","volume":"35","author":"P Grenard","year":"2001","unstructured":"Grenard, P. et al. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J. Hepatol. 35, 367\u2013375 (2001).","journal-title":"J. Hepatol."},{"key":"BFsrep40995_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00726-004-0094-4","volume":"26","author":"EAM Verderio","year":"2004","unstructured":"Verderio, E. A. M., Johnson, T. & Griffin, M. Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 26, 387\u2013404 (2004).","journal-title":"Amino Acids"},{"key":"BFsrep40995_CR37","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1172\/JCI119490","volume":"99","author":"TS Johnson","year":"1997","unstructured":"Johnson, T. S. et al. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J. Clin. Invest. 99, 2950\u20132960 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFsrep40995_CR38","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1681\/ASN.V10102146","volume":"10","author":"TS Johnson","year":"1999","unstructured":"Johnson, T. S. et al. Transglutaminase transcription and antigen translocation in experimental renal scarring. J. Am. Soc. Nephrol. 10, 2146\u20132157 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFsrep40995_CR39","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1097\/01.ASN.0000079614.63463.DD","volume":"14","author":"TS Johnson","year":"2003","unstructured":"Johnson, T. S. et al. Tissue Transglutaminase and the Progression of Human Renal Scarring. J. Am. Soc. Nephrol. 14, 2052\u20132062 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFsrep40995_CR40","first-page":"161","volume":"135","author":"RA Sobel","year":"1989","unstructured":"Sobel, R. A. & Mitchell, M. E. Fibronectin in multiple sclerosis lesions. Am. J. Pathol. 135, 161\u20138 (1989).","journal-title":"Am. J. Pathol."},{"key":"BFsrep40995_CR41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.jnen.0000173894.09553.13","volume":"64","author":"J Van Horssen","year":"2005","unstructured":"Van Horssen, J., B\u00f6, L., Vos, C. M. P., Virtanen, I. & de Vries, H. E. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J. Neuropathol. Exp. Neurol. 64, 722\u20139 (2005).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFsrep40995_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/brain\/aws313","volume":"136","author":"JMJ Stoffels","year":"2013","unstructured":"Stoffels, J. M. J. et al. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain 136, 116\u201331 (2013).","journal-title":"Brain"},{"key":"BFsrep40995_CR43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.tins.2005.07.004","volume":"28","author":"H Colognato","year":"2005","unstructured":"Colognato, H., Ffrench-Constant, C. & Feltri, M. L. Human diseases reveal novel roles for neural laminins. Trends Neurosci. 28, 480\u20136 (2005).","journal-title":"Trends Neurosci."},{"key":"BFsrep40995_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mcn.2006.07.001","volume":"33","author":"Z Siskov\u00e1","year":"2006","unstructured":"Siskov\u00e1, Z., Baron, W., de Vries, H. & Hoekstra, D. Fibronectin impedes \u2018myelin\u2019 sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol. Cell. Neurosci. 33, 150\u20139 (2006).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFsrep40995_CR45","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/glia.21204","volume":"59","author":"ME Van Strien","year":"2011","unstructured":"Van Strien, M. E. et al. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination. Glia 59, 1622\u20131634 (2011).","journal-title":"Glia"},{"key":"BFsrep40995_CR46","first-page":"1585","volume":"26","author":"T Skripuletz","year":"2011","unstructured":"Skripuletz, T., Gudi, V., Hackstette, D. & Stangel, M. De- and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected. Histol. Histopathol. 26, 1585\u20131597 (2011).","journal-title":"Histol. Histopathol."},{"key":"BFsrep40995_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1046\/j.1365-2990.2003.00491.x","volume":"29","author":"JE Holley","year":"2003","unstructured":"Holley, J. E., Gveric, D., Newcombe, J., Cuzner, M. L. & Gutowski, N. J. Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29, 434\u201344 (2003).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFsrep40995_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp, M., Clarner, T., Dang, J., Copray, S. & Beyer, C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118, 723\u201336 (2009).","journal-title":"Acta Neuropathol."},{"key":"BFsrep40995_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/aws262","volume":"136","author":"T Skripuletz","year":"2013","unstructured":"Skripuletz, T. et al. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136, 147\u201367 (2013).","journal-title":"Brain"},{"key":"BFsrep40995_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","volume":"26","author":"P Van der Valk","year":"2000","unstructured":"Van der Valk, P. & De Groot, C. J. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 26, 2\u201310 (2000).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFsrep40995_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1742-2094-9-40","volume":"9","author":"AR Guerrero","year":"2012","unstructured":"Guerrero, A. R. et al. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J. Neuroinflammation 9, 40 (2012).","journal-title":"J. Neuroinflammation"},{"key":"BFsrep40995_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/excr.1999.4633","volume":"252","author":"CA Gaudry","year":"1999","unstructured":"Gaudry, C. A., Verderio, E., Jones, R. A., Smith, C. & Griffin, M. Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp. Cell Res. 252, 104\u201313 (1999).","journal-title":"Exp. Cell Res."},{"key":"BFsrep40995_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000113599","volume":"45","author":"ENTP Bakker","year":"2008","unstructured":"Bakker, E. N. T. P., Pistea, A. & VanBavel, E. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J. Vasc. Res. 45, 271\u20138 (2008).","journal-title":"J. Vasc. Res."},{"key":"BFsrep40995_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/01.RES.0000151333.56089.66","volume":"96","author":"ENTP Bakker","year":"2005","unstructured":"Bakker, E. N. T. P. et al. Small artery remodeling depends on tissue-type transglutaminase. Circ. Res. 96, 119\u201326 (2005).","journal-title":"Circ. Res."},{"key":"BFsrep40995_CR55","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1242\/jcs.00670","volume":"116","author":"I Wierzbicka-Patynowski","year":"2003","unstructured":"Wierzbicka-Patynowski, I. & Schwarzbauer, J. E. The ins and outs of fibronectin matrix assembly. J. Cell Sci. 116, 3269\u201376 (2003).","journal-title":"J. Cell Sci."},{"key":"BFsrep40995_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.matbio.2005.06.008","volume":"24","author":"Y Mao","year":"2005","unstructured":"Mao, Y. & Schwarzbauer, J. E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 24, 389\u2013399 (2005).","journal-title":"Matrix Biol."},{"key":"BFsrep40995_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima, G. K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107\u2013116 (2001).","journal-title":"Brain Pathol"},{"key":"BFsrep40995_CR58","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2008.070850","volume":"172","author":"T Skripuletz","year":"2008","unstructured":"Skripuletz, T. et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172, 1053\u201361 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFsrep40995_CR59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/AN20120062","volume":"4","author":"N Hibbits","year":"2012","unstructured":"Hibbits, N., Yoshino, J., Le, T. Q. & Armstrong, R. C. Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for Remyelination. ASN Neuro 4, 393\u2013408 (2012).","journal-title":"ASN Neuro"},{"key":"BFsrep40995_CR60","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.bbi.2011.05.003","volume":"25","author":"M Kipp","year":"2011","unstructured":"Kipp, M. et al. BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain. Behav. Immun. 25, 1554\u201368 (2011).","journal-title":"Brain. Behav. Immun."},{"key":"BFsrep40995_CR61","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1074\/jbc.272.6.3724","volume":"272","author":"A Monsonego","year":"1997","unstructured":"Monsonego, A. et al. Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J. Biol. Chem. 272, 3724\u20133732 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFsrep40995_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.febslet.2004.10.074","volume":"578","author":"A Campisi","year":"2004","unstructured":"Campisi, A. et al. Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures. FEBS Lett. 578, 80\u201384 (2004).","journal-title":"FEBS Lett"},{"key":"BFsrep40995_CR63","doi-asserted-by":"publisher","first-page":"25402","DOI":"10.1074\/jbc.M109.097162","volume":"285","author":"J Stamnaes","year":"2010","unstructured":"Stamnaes, J., Pinkas, D. M., Fleckenstein, B., Khosla, C. & Sollid, L. M. Redox regulation of transglutaminase 2 activity. J. Biol. Chem. 285, 25402\u20139 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep40995_CR64","doi-asserted-by":"publisher","first-page":"37866","DOI":"10.1074\/jbc.M111.287490","volume":"286","author":"X Jin","year":"2011","unstructured":"Jin, X. et al. Activation of extracellular transglutaminase 2 by thioredoxin. J. Biol. Chem. 286, 37866\u201373 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFsrep40995_CR65","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","volume":"47","author":"J Praet","year":"2014","unstructured":"Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A. & Ponsaerts, P. Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis. Neurosci. Biobehav. Rev. 47, 485\u2013505 (2014).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep40995_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"La Pasquini","year":"2007","unstructured":"Pasquini, L. a. et al. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 32, 279\u2013292 (2007).","journal-title":"Neurochem. Res"},{"key":"BFsrep40995_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12640-013-9380-9","volume":"24","author":"K B\u00e9nardais","year":"2013","unstructured":"B\u00e9nardais, K. et al. Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox. Res. 24, 244\u2013250 (2013).","journal-title":"Neurotox. Res."},{"key":"BFsrep40995_CR68","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.aanat.2013.03.004","volume":"195","author":"A Azami Tameh","year":"2013","unstructured":"Azami Tameh, A. et al. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain. Ann. Anat. 195, 415\u2013423 (2013).","journal-title":"Ann. Anat"},{"key":"BFsrep40995_CR69","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.4049\/jimmunol.167.5.2964","volume":"167","author":"EJ McMahon","year":"2001","unstructured":"McMahon, E. J., Cook, D. N., Suzuki, K. & Matsushima, G. K. Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J. Immunol. 167, 2964\u20132971 (2001).","journal-title":"J. Immunol."},{"key":"BFsrep40995_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(87)90055-4","volume":"78","author":"DA Bakker","year":"1987","unstructured":"Bakker, D. A. & Ludwin, S. K. Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J. Neurol. Sci. 78, 125\u2013137 (1987).","journal-title":"J. Neurol. Sci."},{"key":"BFsrep40995_CR71","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.nbd.2006.08.005","volume":"24","author":"J Van Horssen","year":"2006","unstructured":"Van Horssen, J., B\u00f6, L., Dijkstra, C. D. & de Vries, H. E. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol. Dis. 24, 484\u201391 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFsrep40995_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1128\/MCB.21.1.148-155.2001","volume":"21","author":"VDe Laurenzi","year":"2001","unstructured":"Laurenzi, V. De & Melino, G. Gene Disruption of Tissue Transglutaminase Gene Disruption of Tissue Transglutaminase. Mol. Cell. Biol. 21, 148\u2013155 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep40995_CR73","first-page":"90","volume":"2","author":"KJ Doorn","year":"2014","unstructured":"Doorn, K. J. et al. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients. Acta Neuropathol. Commun. 2, 90 (2014).","journal-title":"Acta Neuropathol. Commun"},{"key":"BFsrep40995_CR74","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuint.2011.03.004","volume":"58","author":"R Verhaar","year":"2011","unstructured":"Verhaar, R. et al. Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of a-synuclein in a cellular model of Parkinson\u2019s disease. Neurochem. Int. 58, 785\u2013793 (2011).","journal-title":"Neurochem. Int."},{"key":"BFsrep40995_CR75","doi-asserted-by":"publisher","first-page":"20569","DOI":"10.1038\/srep20569","volume":"6","author":"MMM Wilhelmus","year":"2016","unstructured":"Wilhelmus, M. M. M., de Jager, M., Smit, A. B., van der Loo, R. J. & Drukarch, B. Catalytically active tissue transglutaminase colocalises with A\u03b2 pathology in Alzheimer\u2019s disease mouse models. Sci. Rep. 6, 20569 (2016).","journal-title":"Sci. Rep"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep40995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40995","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:36:13Z","timestamp":1671842173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep40995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,20]]}},"alternative-id":["BFsrep40995"],"URL":"https:\/\/doi.org\/10.1038\/srep40995","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]},"assertion":[{"value":"21 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40995"}}